基本信息 |
|
产品名称: | ADJUPRIME(TM) IMMUNE MODULATOR |
英文同义词: | ADJUPRIME(TM) IMMUNE MODULATOR |
MDL号: | MFCD00161957 |
氢键受体数量: | 0 |
氢键供体数量: | 0 |
InChi: | InChI=1S// |
InChiKey: | InChIKey=MOSFIJXAXDLOML-UHFFFAOYSA-N |
性质 |
|
注解: | COMMENT 1: ADJUVANTS ARE NONSPECIFIC STIMULATORS OF THE IMMUNE RESPONSE COMMENT 2: WHEN MIXED WITH AN ANTIGEN OR IMMUNOGEN, THEY HELP TO DEPOSIT OR SEQUESTER THE INJECTED MATERIAL COMMENT 3: IN ADDITION, THEY CAUSE A DRAMATIC INCREASE IN THE RESULTANT ANTIBODY RESPONSE COMMENT 4: AN ADJUVANT IS NOT THE SAME THING AS A CARRIER PROTEIN COMMENT 5: A HAPTEN WILL BECOME IMMUNOGENIC WHEN CONJUGATED COVALENTLY TO A CARRIER PROTEIN COMMENT 6: THE HAPTEN WILL NOT BECOME IMMUNOGENIC IF IT IS MERELY ADDED TO AN ADJUVANT COMMENT 7: CONSEQUENTLY, AN ADJUVANT ENHANCES THE IMMUNE RESPONSE TO IMMUNOGENS, BUT IT CANNOT RENDER HAPTENS IMMUNOGENIC DISADVANTAGES: DOES NOT ELICIT AS STRONG AN IMMUNE RESPONSE AS FCA FEATURES/BENEFITS: ELICITS ABOUT 70% OF THE IMMUNE RESPONSE ELICITED BY FCA FEATURES/BENEFITS: MIXES EASILY WITH IMMUNOGEN IN AQUEOUS SOLUTIONS FEATURES/BENEFITS: NO HARMFUL SIDE EFFECTS FEATURES/BENEFITS: NONTOXIC, WATER-SOLUBLE CARBOHYDRATE-BASED ADJUVANT FEATURES/BENEFITS: STIMULATION OF IL-1 (T CELL STIMULATION) |
安全信息 |
* If the product has intellectual property rights, a license granted is must or contact us.
2010-2021 © Chemical Cloud Database. ALL Rights Reserved.浙ICP备11020424号-1 浙公网安备 33010802004002号